Background. Patients colonized with carbapenem-resistant Enterobacteriaceae (CRE) are at higher risk of developing CRE infection after liver transplantation (LT), with associated high morbidity and mortality. Prediction model for CRE infection after LT among carriers could be useful to target preventive strategies.Methods. Multinational multicenter cohort study of consecutive adult patients underwent LT and colonized with CRE before or after LT, from January 2010 to December 2017. Risk factors for CRE infection were analyzed by univariate analysis and by Fine-Gray subdistribution hazard model, with death as competing event. A nomogram to predict 30- and 60-day CRE infection risk was created.Results. A total of 840 LT recipients found to be colonized with CRE before (n = 203) or after (n = 637) LT were enrolled. CRE infection was diagnosed in 250 (29.7%) patients within 19 (interquartile range [IQR], 9-42) days after LT. Pre- and post-LT colonization, multisite post-LT colonization, prolonged mechanical ventilation, acute renal injury, and surgical reintervention were retained in the prediction model. Median 30- and 60-day predicted risk was 15% (IQR, 11-24) and 21% (IQR, 15-33), respectively. Discrimination and prediction accuracy for CRE infection was acceptable on derivation (area under the curve [AUC], 74.6; Brier index, 16.3) and bootstrapped validation dataset (AUC, 73.9; Brier index, 16.6). Decision-curve analysis suggested net benefit of model-directed intervention over default strategies (treat all, treat none) when CRE infection probability exceeded 10%. The risk prediction model is freely available as mobile application at https://idbologna.shinyapps.io/CREPostOLTPredictionModel/.Conclusions. Our clinical prediction tool could enable better targeting interventions for CRE infection after transplant.

Development of a Risk Prediction Model for Carbapenem-resistant Enterobacteriaceae Infection After Liver Transplantation: A Multinational Cohort Study

Grossi P.
Membro del Collaboration Group
;
Bandera A.;Invernizzi F.;Peghin M.;
2021-01-01

Abstract

Background. Patients colonized with carbapenem-resistant Enterobacteriaceae (CRE) are at higher risk of developing CRE infection after liver transplantation (LT), with associated high morbidity and mortality. Prediction model for CRE infection after LT among carriers could be useful to target preventive strategies.Methods. Multinational multicenter cohort study of consecutive adult patients underwent LT and colonized with CRE before or after LT, from January 2010 to December 2017. Risk factors for CRE infection were analyzed by univariate analysis and by Fine-Gray subdistribution hazard model, with death as competing event. A nomogram to predict 30- and 60-day CRE infection risk was created.Results. A total of 840 LT recipients found to be colonized with CRE before (n = 203) or after (n = 637) LT were enrolled. CRE infection was diagnosed in 250 (29.7%) patients within 19 (interquartile range [IQR], 9-42) days after LT. Pre- and post-LT colonization, multisite post-LT colonization, prolonged mechanical ventilation, acute renal injury, and surgical reintervention were retained in the prediction model. Median 30- and 60-day predicted risk was 15% (IQR, 11-24) and 21% (IQR, 15-33), respectively. Discrimination and prediction accuracy for CRE infection was acceptable on derivation (area under the curve [AUC], 74.6; Brier index, 16.3) and bootstrapped validation dataset (AUC, 73.9; Brier index, 16.6). Decision-curve analysis suggested net benefit of model-directed intervention over default strategies (treat all, treat none) when CRE infection probability exceeded 10%. The risk prediction model is freely available as mobile application at https://idbologna.shinyapps.io/CREPostOLTPredictionModel/.Conclusions. Our clinical prediction tool could enable better targeting interventions for CRE infection after transplant.
2021
2021
CRE carriage; CRE infection; SOT; liver transplantation; Adult; Anti-Bacterial Agents; Carbapenems; Cohort Studies; Humans; Risk Factors; Carbapenem-Resistant Enterobacteriaceae; Enterobacteriaceae Infections; Liver Transplantation
Giannella, M.; Freire, M.; Rinaldi, M.; Abdala, E.; Rubin, A.; Mularoni, A.; Gruttadauria, S.; Grossi, P.; Shbaklo, N.; Tandoi, F.; Ferrarese, A.; Burra, P.; Fernandes, R.; Aranha Camargo, L. F.; Asensio, A.; Alagna, L.; Bandera, A.; Simkins, J.; Abbo, L.; Halpern, M.; Santana Girao, E.; Valerio, M.; Munoz, P.; Fernandez Yunquera, A.; Statlender, L.; Yahav, D.; Franceschini, E.; Graziano, E.; Morelli, M. C.; Cescon, M.; Viale, P.; Lewis, R.; Bartoletti, M.; Pascale, R.; Campoli, C.; Coladonato, S.; Cristini, F.; Tumietto, F.; Siniscalchi, A.; Laici, C.; Ambretti, S.; Romagnoli, R.; De Rosa, F. G.; Muscatello, A.; Mangioni, D.; Gori, A.; Antonelli, B.; Dondossola, D.; Rossi, G.; Invernizzi, F.; Peghin, M.; Cillo, U.; Mussini, C.; Benedetto, F. D.; Terrabuio, D. R. B.; Bittante, C. D.; Toniolo, A. D. R.; Balbi, E.; Garcia, J. H. P.; Morras, I.; Ramos, A.; Cruz, A. F.; Salcedo, M.
File in questo prodotto:
File Dimensione Formato  
giannella_CID.pdf

non disponibili

Tipologia: Versione Editoriale (PDF)
Licenza: Copyright dell'editore
Dimensione 3.06 MB
Formato Adobe PDF
3.06 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11383/2140753
Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 22
  • ???jsp.display-item.citation.isi??? 18
social impact